Literature DB >> 40434

Pneumococcal vaccine: development and prospects.

R Austrian.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 40434     DOI： 10.1016/0002-9343(79)90222-5

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  12 in total

1.  Phosphorylcholine antibodies in pulmonary infection.

Authors:  S Nishinarita; S Sawada; T Horie
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

2.  Effect of splenectomy on first cadaver kidney transplants.

Authors:  F P Stuart; C R Reckard; B L Ketel; J A Schulak
Journal:  Ann Surg       Date:  1980       Impact factor: 12.969

3.  Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae.

Authors:  D E Briles; C Forman; M Crain
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

4.  Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.

Authors:  M J Crain; W D Waltman; J S Turner; J Yother; D F Talkington; L S McDaniel; B M Gray; D E Briles
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

5.  Modified opsonization, phagocytosis, and killing assays to measure potentially protective antibodies against pneumococcal surface protein A.

Authors:  Calvin C Daniels; Kyung-Hyo Kim; Robert L Burton; Shaper Mirza; Melissa Walker; Janice King; Yvette Hale; Patricia Coan; Dong-Kwon Rhee; Moon H Nahm; David E Briles
Journal:  Clin Vaccine Immunol       Date:  2013-08-07

6.  Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.

Authors:  D E Briles; C Forman; J C Horowitz; J E Volanakis; W H Benjamin; L S McDaniel; J Eldridge; J Brooks
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

7.  Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae.

Authors:  D S Chudwin; S G Artrip; A Korenblit; G Schiffman; S Rao
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.

Authors:  D E Briles; M Nahm; K Schroer; J Davie; P Baker; J Kearney; R Barletta
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

9.  C3b/iC3b deposition on Streptococcus pneumoniae is not affected by HIV infection.

Authors:  Catherine Hyams; Jerry C H Tam; Jeremy S Brown; Stephen B Gordon
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

10.  Epidemiological studies of Streptococcus pneumoniae in infants: development of antibody to phosphocholine.

Authors:  B M Gray; H C Dillon; D E Briles
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.